What's new in geriatric oncology?;Quoi de neuf dans l'organisation de l'oncogériatrie?

Bulletin du Cancer

Volumn 93, Issue 1, 2006, Pages 119-123

  Terret, Catherine ^a   Albrand, Gilles ^b   Jeanton, Martine ^b   Courpron, Philippe ^b   Droz, Jean Pierre ^a  

^a CENTRE LÉON BÉRARD   (France)

^b HOSPICES CIVILS DE LYON   (France)

Author keywords

Cancer in the elderly; Geriatric oncology; Older cancer patients

Indexed keywords

CANCER; CANCER PATIENT; CANCER RESEARCH; CANCER THERAPY; GERIATRIC CARE; GERIATRIC PATIENT; GERIATRICS; HUMAN; LIFE EXPECTANCY; ONCOLOGY; REVIEW; SOCIAL SUPPORT; TREATMENT PLANNING;

AGED; EUROPE; GERIATRICS; HUMANS; INCIDENCE; LIFE EXPECTANCY; MEDICAL ONCOLOGY; NEOPLASMS; PATIENT CARE PLANNING; PATIENT CARE TEAM; QUALITY OF LIFE;

EID: 33144473047     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Zulian G, Terret C, Droz JP. Interdépendance de l'oncologue et du gériatre. Med Hyg (Geneve) 2003; 61: 1016-98.
2. Brutel C. Projection de population à l'horizon 2050. Un vieillissement inéluctable. Insee Première 2001; 762 (www.insee.fr).
3. Remontet L, Estève J, Bouviet AM, Grosclaude P, Launois G, Menegoz F, et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique 2003; 51: 3-30.
4. Yancik R, Ries LA. Cancer in older persons: an international issue in an aging world. Semin Oncol 2004; 31: 128-36.
5. Talarico L, Chen G, Pazdur R. Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration. J Clin Oncol 2004; 22: 4626-31.
6. Terret C, Gaujard S, Droz JP. Actualités en oncogériatrie. Bull Cancer 2003; 90: 93-6.
7. Balducci L, Extermann M. Management of cancer in the older person: a practical approach. Oncologist 2000; 5: 224-37.
8. Terret C, Zulian G, Droz JP. Statements on the interdependence between the oncologist and the geriatrician in geriatric oncology. Crit Rev Oncol Hematol 2004; 52: 127-33.
9. Braud AC, Joly F, Rios M, Felizot L, Fargeot P, Servent V, et al. Preservation of Activities Daily Living (ADL) in a phase-II impact study of oral capecitabine and vinorelbine in the treatment of metastatic carcinomas in patients 70 and older: The GERICO-01 Study by the French FNCLCC Group. J Clin Oncol 2004; 22(14S): 765.
10. Aparicio T, Desrame J, Lecomte T, Mitry E, Belloc J, Etienney I, et al. Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly. Br J Cancer 2003; 89: 1439-44.
11. Mabro M, Gilles-Amar V, Louvet C, Carola E, Maindrault-Goebel F, de Gramont A, et al. Bimonthly 5-fluorouracil in elderly patients with metastatic colorectal cancer. Study of 50 patients. Rev Med Interne 1999; 20: 863-8.
12. Carola E, Mabro M, Brain E, Angelier E, Bouleuc C. Survival without quality of life decrease in old women with metastatic breast cancer treated by chemotherapy. 4th meeting of SIOG, Roma 2003.
13. Freyer G, Geay JF, Touzet S, Provencal J, Weber B, Jacquin JP, et al. Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a Gineco study. Ann Oncol 2005; 16: 1795-800.
14. Freyer G, Lortholary A, Delcambre C, Delozier T, Piot G, Genin F, et al. Unexpected toxicities in elderly patients treated with oral idarubicin in metastatic breast cancer: the GINECO experience. Clin Oncol (R Coll Radiol) 2004; 16: 17-23.
15. Feugier P, Van Hoof A, Sebban C, Solal-Celigny P, Bouabdallah R, Ferme C, et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Étude des Lymphomes de l'Adulte. J Clin Oncol 2005; 23: 4117-26.
16. Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 235-42.
17. Quoix E, Breton JL, Ducolone A, Mennecier B, Depierre A, Lemarie E, et al. First line chemotherapy with gemcitabine in advanced non-small cell lung cancer elderly patients: a randomized phase II study of 3-week versus 4-week schedule. Lung Cancer 2005; 47: 405-12.
18. Le Caer H, Gimenez C, Fournel P, Chouaid C, Robinet G, Jullian H, et al. A multicenter phase II study of docetaxel/gemcitabine weekly in advanced non-small cell lung cancer (NSCLC) in elderly and/or poor performance status (PS) patients (pts). Preliminary results of the 02-02 Groupe Français de Pneumo-Cancérologie (GFPC) study. J Clin Oncol 2005; 23(16S): 657.
19. Hoang-Xuan K, Taillandier L, Chinot O, Soubeyran P, Bogdhan U, Hildebrand J, et al. Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group. J Clin Oncol 2003; 21: 2726-31.
20. Repetto L, Carreca I, Maraninchi D, Aapro M, Calabresi P, Balducci L. Use of growth factors in the elderly patient with cancer: a report from the Second International Society for Geriatric Oncology (SIOG) 2001 meeting. Crit Rev Oncol Hematol 2003; 45: 123-8.
21. Extermann M, Aapro M, Bernabei R, Cohen HJ, Droz JP, Lichtman S, et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology. Crit Rev in Oncol Hematol 2005; 55: 241-52.
22. Repetto L, Biganzoli L, Koehne CH, Luebbe AS, Soubeyran P, Tjan-Heijnen VC, et al. EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer. Eur J Cancer 2003; 48: 227-37.